ArticleCancer medicine2019

TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma.

Hiroshi Moritake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.